Table 5.

Univariate analysis and multivariate analysis for cardiac death

	Univariate analysis			Multivariate analysis
	HR	95% CI	P Value	HR	95% CI	P Value
Old age (>60 y)	3.11	2.53‐3.83	<0.001	2.22	1.72‐2.85	<0.001
Male gender	0.58	0.49‐0.69	<0.001	0.86	0.70‐1.06	0.148
Hypertension	1.77	1.50‐2.09	<0.001	1.24	1.01‐1.52	0.036
Diabetes mellitus	1.99	1.69‐2.35	<0.001	1.37	1.13‐1.66	0.002
Dyslipidemia	0.67	0.50‐0.90	0.009	0.73	0.53‐1.01	0.060
Body mass index (>24 kg/m2)	0.64	0.54‐0.76	<0.001	0.85	0.71‐1.03	0.099
LV dysfunction (EF < 50%)	2.11	1.79‐2.50	<0.001	1.58	1.30‐1.91	<0.001
Renal failure (Cr > 2.0 mg/dL)	4.98	4.05‐6.12	<0.001	2.52	1.94‐3.29	<0.001
Current smoking	0.58	0.48‐0.69	<0.001	1.10	0.88‐1.37	0.422
Multivessel disease & LM disease	1.55	1.31‐1.85	<0.001	1.22	1.02‐1.47	0.034
STEMI vs NSTEMI	0.60	0.50‐0.70	<0.001	0.67	0.56‐0.82	<0.001
Killip class >2	2.98	2.47‐3.58	<0.001	1.63	1.31‐2.04	<0.001
Medication use
beta‐blocker	0.57	0.47‐0.69	<0.001	0.76	0.61‐0.96	0.019
RAAS blocker	0.63	0.52‐0.75	<0.001	0.90	0.73‐1.12	0.350
Statin	0.35	0.28‐0.44	<0.001	0.68	0.51‐0.90	0.006
PP group
>‐20	2.61	1.34‐5.10	0.005	2.37	1.11‐5.05	0.026
21‐30	1.14	0.86‐1.52	0.364	1.25	0.92‐1.70	0.159
31‐40		Reference			Reference
41‐50	1.11	0.90‐1.38	0.326	1.06	0.84‐1.34	0.604
51‐60	1.42	1.11‐1.82	0.005	1.08	0.82‐1.42	0.595
61‐70	1.57	1.11‐2.24	0.012	0.93	0.61‐1.41	0.737
71‐80	3.06	2.14‐4.37	<0.001	1.36	0.90‐2.04	0.141

Abbreviations: CI, confidence interval; EF, ejection fraction; HR, hazard ratio; LM, left main; (N)STEMI, (non)‐ST elevation myocardial infarction; PP, pulse pressure; RAAS, renin‐aldosterone‐angiotensin system.